Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics. | Br J Cancer | 2023 | 37117649 | PubTator, text mining | PubMed |
| PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion. | Cell Rep | 2023 | 37115668 | PubTator, text mining | PubMed |
| The Tox Gene Encodes Two Proteins with Distinct and Shared Roles in Gene Regulation. | J Immunol | 2023 | 37115203 | PubTator, text mining | PubMed |
| Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma. | Front Pharmacol | 2023 | 37113755 | PubTator, text mining | PubMed |
| Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. | Pharmaceutics | 2023 | 37111629 | PubTator, text mining | PubMed |
| SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation. | Genes (Basel) | 2023 | 37107702 | PubTator, text mining | PubMed |
| Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2. | Nat Immunol | 2023 | 37106039 | PubTator, text mining | PubMed |
| Mycosis fungoides and Sézary syndrome. | Blood Res | 2023 | 37105561 | PubTator, text mining | PubMed |
| Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer. | iScience | 2023 | 37091230 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells. | Nat Immunol | 2023 | 37081150 | PubTator, text mining | PubMed |
| Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer. | Oncogenesis | 2023 | 37080999 | PubTator, text mining | PubMed |
| Nodal reactive proliferation of monocytoid B-cells may represent atypical memory B-cells. | J Microbiol Immunol Infect | 2023 | 37080839 | PubTator, text mining | PubMed |
| Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. | J Immunother Cancer | 2023 | 37080610 | PubTator, text mining | PubMed |
| Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer. | Cancer Control | 2023 | 37078136 | PubTator, text mining | PubMed |
| Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC. | Front Immunol | 2023 | 37077914 | PubTator, text mining | PubMed |
| mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity. | Cancer Immunol Res | 2023 | 37074216 | PubTator, text mining | PubMed |
| Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. | J Immunother Cancer | 2023 | 37072348 | PubTator, text mining | PubMed |
| MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production. | Mol Cancer Res | 2023 | 37071397 | PubTator, text mining | PubMed |
| The Chromatin Landscape of Pathogenic Transcriptional Cell States in Rheumatoid Arthritis. | bioRxiv | 2023 | 37066336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=28